The Chernin Group-backed personalised care provider plans to use the series B funding to expand into new cities and take its telemedicine offering nationwide.
Parsley Health, a US-based personalised medicine provider backed by over-the-top media company Chernin Group, has secured $26m in a series B round led by technology investment platform White Star Capital.
The round also featured FirstMark Capital, Amplo, Alpha Edison, Arkitekt Ventures, Galaxy Digital and private investors including Nat Turner and Tom Lee. It was closed in the summer of this year but formally announced late last week.
Founded in 2016, Parsley provides personalised healthcare targeted at those suffering from chronic…
